VAXX - Vaxxinity to Present at Upcoming Investor Conferences in September | Benzinga
CAPE CANAVERAL, Fla., Aug. 29, 2023 (GLOBE NEWSWIRE) -- Vaxxinity, Inc. (NASDAQ:VAXX), a U.S. company pioneering the development of a new class of medicines, today announced that Mei Mei Hu, Chief Executive Officer of Vaxxinity, will present and participate in meetings at the following investor conferences in New York in September:
H.C. Wainwright 25th Annual Global Investment Conference
Date: Monday, September 11, 2023
Time: 5:00 – 5:30 p.m. (ET)
Format: Corporate Presentation
A live webcast of the H.C. Wainwright presentation will be available under "Events & Presentations" in the Investor section of the Company's website and will be available for replay for 90 days following the event.
Baird Global Healthcare Conference
Date: Tuesday, September 12, 2023
Time: 11:25 – 11:55 a.m. (ET)
Format: Corporate Presentation
All presentation times subject to change.
About Vaxxinity
Vaxxinity, Inc. is a purpose-driven biotechnology company committed to democratizing healthcare across the globe. The company is pioneering a new class of medicines aimed at disrupting the existing treatment paradigm for chronic disease, increasingly dominated by monoclonal antibodies, which suffer from prohibitive costs and cumbersome administration. The company's proprietary technology platform has enabled the innovation of novel synthetic peptide immunotherapy candidates designed to bring the efficiency of vaccines to the treatment of chronic diseases, including Alzheimer's disease, Parkinson's disease, migraine, and hypercholesterolemia. The technology is also implemented as part of a COVID-19 vaccine program. Vaxxinity has optimized its pipeline to achieve ...